• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Introduction to (4,5-Dimethyl-1H-benzimidazol-2-yl)methylamine hydrochloride (CAS No. 1119451-11-4)

(4,5-Dimethyl-1H-benzimidazol-2-yl)methylamine hydrochloride, identified by the CAS number 1119451-11-4, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to the benzimidazole derivative class, a group of molecules known for their diverse biological activities and potential therapeutic applications. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and drug formulation.

The< strong>benzimidazole core structure of this compound is a key feature that contributes to its pharmacological properties. Benzimidazoles are widely recognized for their role in various biological processes, including DNA intercalation, enzyme inhibition, and receptor binding. The presence of< strong>methylamine substituents at the 2-position of the benzimidazole ring introduces additional functional groups that can modulate the compound's interactions with biological targets. This modification opens up possibilities for designing molecules with enhanced binding affinity and selectivity.

In recent years, there has been a growing interest in< strong>benzimidazole derivatives as lead compounds for the development of new drugs. Their structural versatility allows for the creation of molecules with tailored properties, making them suitable for targeting a wide range of diseases. One of the most notable areas of research involving benzimidazole derivatives is in the treatment of cancer. These compounds have shown promise in inhibiting kinases and other enzymes involved in tumor growth and progression.

The< strong>methylamine moiety in (4,5-Dimethyl-1H-benzimidazol-2-yl)methylamine hydrochloride is particularly interesting from a chemical perspective. Methylamine can act as a hydrogen bond acceptor and donor, which can influence the compound's solubility and binding interactions. Additionally, the hydrochloride salt form ensures that the compound remains stable under various storage conditions, making it easier to handle and utilize in laboratory settings.

Recent studies have explored the potential of< strong>benzimidazole derivatives as antimicrobial agents. The unique structural features of these compounds allow them to disrupt bacterial cell wall synthesis and interfere with essential metabolic pathways. For instance, certain benzimidazoles have been found to inhibit bacterial gyrase, an enzyme crucial for DNA replication in bacteria. This mechanism of action makes them effective against a broad spectrum of bacterial infections.

The< strong>hydrochloride salt form of (4,5-Dimethyl-1H-benzimidazol-2-yl)methylamine hydrochloride also plays a crucial role in its pharmaceutical applications. Salts are often used to improve the bioavailability of active pharmaceutical ingredients (APIs) by enhancing their solubility in water-based media. This property is particularly important for oral formulations, where poor solubility can lead to low absorption rates and reduced therapeutic efficacy.

In addition to their antimicrobial properties, benzimidazole derivatives have shown potential in other therapeutic areas, such as anti-inflammatory and antiviral treatments. The< strong>methylamine substituent can influence the compound's ability to interact with inflammatory mediators and viral enzymes, providing a basis for developing novel therapeutic strategies.

The synthesis of< strong>(4,5-Dimethyl-1H-benzimidazol-2-yl)methylamine hydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The benzimidazole core is typically synthesized through condensation reactions between o-halobenzamides and ammonia or amines. Subsequent functionalization at the 2-position with methylamine followed by salt formation yields the desired product.

The< strong>CAS number 1119451-11-4 provides a unique identifier for this compound, facilitating its recognition and classification in chemical databases and literature. This standardized naming system is essential for ensuring accurate communication among researchers and regulatory agencies.

In conclusion, (4,5-Dimethyl-1H-benzimidazol-2-yl)methylamine hydrochloride is a versatile compound with significant potential in pharmaceutical research. Its unique structural features and functional groups make it a valuable building block for designing molecules with diverse biological activities. Ongoing research continues to uncover new applications for this compound, highlighting its importance in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)